Lumexa Imaging Holdings, Inc. — Cyborg Score 7/10

Strong
Diagnostic Imaging Services / Healthcare Facilities & Services

Strategic Profile

The company offers a range of advanced imaging services including MRI, CT and PET scans, as well as routine diagnostic and screening imaging services like X-ray, ultrasound and mammography. Lumexa set a company record by opening nine de novo centers in 2025, demonstrating aggressive expansion and capitalizing on secular shifts toward outpatient imaging.

Cyborg Score Rationale

Lumexa reported preliminary 2025 Adjusted EBITDA of $229.0M with higher advanced imaging volumes and strong PET growth, while system-wide total procedures reached 3,972,228 in 2025 with advanced procedures and PET volumes growing faster than overall volume. Recent IPO success and institutional investor interest provide capital for continued de novo expansion.

Top Insights

  • Record de novo expansion in 2025 with nine new centers, demonstrating execution capability and scalable business model
  • Strong Adjusted EBITDA growth (14% YoY) despite GAAP losses, indicating improving underlying operating performance
  • Institutional investment traction with major positions from Janus Henderson, Invesco, and pension plans in Q4 2025
  • Advanced imaging and PET procedures growing faster than total volume mix, improving service revenue composition

Named Competitors

  • Hospital-Based Imaging Networks — Integrated hospital imaging departments with patient referral networks
  • Independent Imaging Centers — Smaller, regional diagnostic imaging providers
  • National Imaging Chains — Comparable scale outpatient imaging platforms

Recent Developments

  • (March 2026) Preliminary 2025 results show Adjusted EBITDA of $229M, 14% growth YoY; announced 2026 guidance
  • (January 2026) Achieved record nine de novo center openings in 2025; now operates 185+ centers across 13 states
  • (December 2025) IPO priced at $18.50/share; raised $462.5M on NASDAQ, valuing company at ~$1.76B initially
  • (July 2025) Rebranded from US Radiology Specialists to Lumexa Imaging to reflect growth and innovation focus

Open the full interactive Lumexa Imaging Holdings, Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →